GE HealthCare Technologies exceeded expectations in Q3, with strong demand for medical devices in the US and EMEA region. Revenue from imaging devices rose 5% to $2.35 billion, contributing to total sales of $5.14 billion. The company raised its adjusted profit forecast for 2025 to $4.51-$4.63 per share. Sales in China fell 3% due to disruptions and delays.

Read more at Yahoo Finance: GE HealthCare boosts 2025 profit view after strong US demand helps third quarter